Cargando…
Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
Cancer is the second leading cause of death worldwide. Specially, the high incidence rate and prevalence of drug resistance have rendered prostate cancer (PCa) a great threat to men’s health. Novel modalities with different structures or mechanisms are in urgent need to overcome these two challenges...
Autores principales: | Ye, Qingmei, Zhou, Xin, Han, Fangxuan, Zheng, Caijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060886/ https://www.ncbi.nlm.nih.gov/pubmed/37007051 http://dx.doi.org/10.3389/fchem.2023.1137547 |
Ejemplares similares
-
Bufadienolides originated from toad source and their anti-inflammatory activity
por: Zou, Denglang, et al.
Publicado: (2022) -
Effect of exposure to deltamethrin on the bufadienolide profiles in Bufo bufo gargarizans venom determined by ultra-performance liquid chromatography-triple quadrupole mass spectrometry
por: Zhou, Jing, et al.
Publicado: (2019) -
Does the Glucocorticoid Stress Response Make Toads More Toxic? An Experimental Study on the Regulation of Bufadienolide Toxin Synthesis
por: Üveges, B, et al.
Publicado: (2023) -
An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
por: Ye, Qingmei, et al.
Publicado: (2023) -
Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells
por: Yu, Zhenlong, et al.
Publicado: (2014)